Zhong Deng

Dr. Zhong Deng


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Cancer Science
Verified
Journal Article
Open access
JYJia Yang
Jia Yang
XWXujia Wu
Xujia Wu
JWJia Wang
Jia Wang
XGXing Guo
Xing Guo
JCJunju Chen
Junju Chen
ZDZhong Deng
Zhong Deng
YAP/TAZ have been identified as master regulators in malignant phenotypes of glioblastoma (GBM); however, YAP/TAZ transcriptional disruptor in GBM treatment remains ineffective. Whether post‐transcriptional dysregulation of YAP/TAZ improves GBM outcome is currently unknown. Here, we report that insulin‐like growth factor 2 (IGF2) mRNA‐binding protein 1 (IGF2BP1 or IMP1) is upregulated in mesenchymal GBM compared with proneural GBM and correlates with worse patient outcome. Overexpression of IMP1 in proneural glioma stem‐like cells (GSCs) promotes while IMP1 knockdown in mesenchymal GSCs attenuates tumorigenesis and mesenchymal signatures. IMP1 binds to and stabilizes m6A‐YAP mRNA, leading to activation of YAP/TAZ signaling, depending on its m6A recognition and binding domain. On the other hand, TAZ functions as enhancer for IMP1 expression. Collectively, our data reveal a feedforward loop between IMP1 and YAP/TAZ maintaining GBM/GSC tumorigenesis and malignant progression and a promising molecular target in GBM.


1 August 2021 in World Neurosurgery
Verified
Journal Article
Open access
ZDZhong Deng
Zhong Deng
XLXixi Li
Xixi Li
JYJia Yang
Jia Yang
HYHai Yu
Hai Yu
NZNu Zhang
Nu Zhang
To examine the impact of marital status on the mortality of patients with primary malignant brain tumors excluding bias from basic characteristics and treatment. We used the Surveillance, Epidemiology, and End Results program to identify 81,277 patients diagnosed in 2000 through 2016 with the most common primary malignant brain tumors, including glioma, ependymoma and medulloblastoma. To avoid bias, we used propensity score matching method to match 44,854 patients with complete clinical and follow-up information. Then, we used Cox regression and Kaplan-Meier survival analysis to investigate the impact of marital status on cancer patient mortality. Married patients were more likely to received surgery and adjuvant chemo- or radio-therapy than single, and divorce, separated and widowed (DSW) patients (all p<0.001). Married patients with high grade glioma were more likely to survive longer and less likely to die of their malignance compared to single (adjusted odds ratio [OR] 1.120; 95% CI, 1.069 to 1.174; p<0.001; and OR 1.078; 95% CI, 1.025 to 1.133; p=0.003; respectively), and DSW patients (OR 1.117; 95% CI, 1.074 to 1.161; p<0.001; and OR 1.090; 95% CI, 1.046 to 1.136; p<0.001; respectively) (all adjusted to the married group). Similar results were identified in patients with low grade glioma but not ependymoma and medulloblastoma. Even after adjusting for known confounders, married patients with HGG and LGG are at higher possibility to have a better outcome. This study highlights the potential significance that intimate support from spouse can improve glioma patient survival.

16 June 2021 in Research Square
Verified
Preprint
Open access
PDF file
ZDZhong Deng
Zhong Deng
YWYichang Wang
Yichang Wang
XLXixi Li
Xixi Li
HTHongxing Tang
Hongxing Tang
JYJia Yang
Jia Yang
TWTuo Wang
Tuo Wang
Introduction To clarify the prognostic value of extent of surgical resection, radiation and chemotherapy in pediatric medulloblastoma patients < 3 years old and ≥ 3 years old. Methods We used the Surveillance, Epidemiology, and End Results program to identify 1,495 pediatric patients diagnosed between 1973 and 2016 with medulloblastoma. Patients with incomplete or unknown clinical information were excluded. Basic characteristics between patients < 3 years old and ≥ 3 years old were compared. Then, we used Cox regression to investigate the impact of extent of surgical resection, radiation and chemotherapy on patient outcome. Results Gross total resection only significantly improved patient outcome in those ≥ 3 years old, and radiation independently correlated to better OS and PFS in patients ≥ 3 years old (all p < 0.05). However, chemotherapy only benefited patient outcome in those < 3 years old (all p < 0.05). Furthermore, in those ≥ 3 years old patients underwent surgical procedures, radiation alone confer survival benefit only in those received gross total resection (p < 0.05) but not in partial resection or biopsy (p > 0.05). Notably, adjuvant radiation plus chemotherapy largely improved patient survival independent of extent of resection (p < 0.05). Conclusions The extent of resection should be differentially considered and applied between pediatric medulloblastoma patients < 3 years old and ≥ 3 years old, so are the adjuvant radio- and chemo- therapies.